Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05769517

Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries

Prediction of Germline BRCA 1/2 Genes Pathogenetic Variants From Healthy Ovaries Ultrasound Images: Radiogenomics as an Innovative Tool to Prevent BRCA-related Cancers

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,300 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The project aims at enhancing performance metrics and prospectively validating a radiogenomics model based on ovarian US images for predicting germline breast cancer susceptibility gene 1 and/or 2 (BRCA) status in women with healthy ovaries. The project is divided in two operational phases: Retrospective phase AIM 1: To define and implement a proper and fine-tuned image preprocessing pipeline on the existing dataset; AIM 2: To enlarge dataset size with new real images from different centers and apply data augmentation techniques, deep neural network models combined with the aforementioned handcrafted imaging features from radiomics analysis; Prospective phase AIM 3: To further cross-validate the predictive model on US images acquired prospectively in an observational multicenter study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGerminal BRCAWe will conduct a multicenter prospective observational study aimed at automatically implementing the predictive model and collecting US images of healthy ovaries from patients tested for germline BRCA pathogenetic variants according to current indications.

Timeline

Start date
2023-03-20
Primary completion
2024-04-01
Completion
2031-03-08
First posted
2023-03-15
Last updated
2026-04-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05769517. Inclusion in this directory is not an endorsement.